Literature DB >> 1794246

[Impairment of the digestive system in high altitude erythrocythemia].

G B Zhao1, L Li.   

Abstract

Among 203 patients with high altitude erythrocythemia (HAE), 89% had various kinds of alimentary canal symptoms, while these were present only in 31% of a control group (P less than 0.01). 49% of the HAE group had stomach, while only 8% of the control group had it. Endoscopic examination revealed 44% of the HAE group had peptic ulcer, being much higher than 6% of the control group. The ratio of gastric to duodenal ulcer in the HAE group was 2 to 1. The HAE patients had higher values of ALT, total bilirubin, LDH activity, LDH1 and LDHs, but lower values of AKP, LDH2, LDH4 and gamma-GT than the controls. The difference was, however, of no statistical significance. B mode ultrasonography showed that the incidence of hepatomegaly and splenomegaly was 24% and 11% respectively in the HAE group, while it was only 4% and 2% in the control group. HAE patients usually had symptoms of digestive system two years after the onset and the incidence at that time was 67%. With the extended course of the disease, the incidence gradually came down. The mechanism of digestive system impairment in HAE was probed and it was shown that treatment of digestive system impairment would promote the healing of HAE.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1794246

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  2 in total

1.  High-altitude gastrointestinal bleeding: an observation in Qinghai-Tibetan railroad construction workers on Mountain Tanggula.

Authors:  Tian-Yi Wu; Shou-Quan Ding; Jin-Liang Liu; Jian-Hou Jia; Rui-Chen Dai; Dong-Chun Zhu; Bao-Zhu Liang; De-Tang Qi; Yong-Fu Sun
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Transcriptome Reveals 1400-Fold Upregulation of APOA4-APOC3 and 1100-Fold Downregulation of GIF in the Patients with Polycythemia-Induced Gastric Injury.

Authors:  Kang Li; Luobu Gesang; Zeng Dan; Lamu Gusang; Ciren Dawa; Yuqiang Nie
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.